Ocugen Stock

Ocugen Interest Coverage

The Interest Coverage Ratio of Ocugen (OCGN) as of Aug 15, 2026 is -14.90.

Interest Coverage

-14.90

Last updated:

Interest Coverage Ratio of Ocugen is 2026 -14.90 . Interest Coverage Ratio of Ocugen was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Ocugen Stock analysis

What does Ocugen do? Ocugen Inc is a US-based biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and vaccines. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania. It has a strong pipeline of products in various stages of development, with a focus on treating eye diseases and other medical conditions. Ocugen has also entered into partnerships for the development and marketing of COVID-19 vaccines, including Covaxin. Overall, Ocugen Inc is expected to be a significant player in the biopharmaceutical industry in the coming years. Ocugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ocugen stock

Interest Coverage Ratio of Ocugen is -14.90 in 2026.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Ocugen since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Ocugen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Ocugen

All Key Metrics — Ocugen